<DOC>
	<DOC>NCT00366522</DOC>
	<brief_summary>To evaluate the safety and tolerability of a single dose of LXR-623 in healthy subjects.</brief_summary>
	<brief_title>Study Evaluating LXR-623 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion: Healthy, men or women, aged 1950 years Exlcusion: Use of any investigational or prescription drug within 30 days before study start Any clinically imprtant medical disease or abnormal laboratory test results</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Healthy</keyword>
	<keyword>healthy subjects</keyword>
</DOC>